These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Study of insulin secretion in chronic pancreatitis]. Michel JP; Hessel L; Laubie B; Claude R Sem Hop; 1976 Dec; 52(44):2535-40. PubMed ID: 188195 [TBL] [Abstract][Full Text] [Related]
48. [The significance of insulin secretion in the pathogenesis of diabetes mellitus]. Verlohren HJ; Lohmann D Z Gesamte Inn Med; 1981 Feb; 36(4):254-6. PubMed ID: 7013305 [No Abstract] [Full Text] [Related]
49. [Behavior of blood levels of I.R.I. in obese persons after endovenous tolubtamide loading]. Artenisio AC; Allegra V; Albanese MC; Sprovieri M; Alibrando S; Caruso A; Corsi V Folia Endocrinol; 1972 Aug; 25(4):286-99. PubMed ID: 4678218 [No Abstract] [Full Text] [Related]
50. [Dynamics of insulin secretion in response to a peroral glucose load and its diagnostic significance]. Baranov VG; Stepanova NA; Tikhonova NE Probl Endokrinol (Mosk); 1980; 26(1):3-8. PubMed ID: 6987642 [TBL] [Abstract][Full Text] [Related]
51. [Diurnal variation of glucose tolerance and insulin secretion in man (author's transl)]. Grabner W; Matzkies F; Prestele H; Rose A; Daniel U; Phillip J; Fischer K Klin Wochenschr; 1975 Aug; 53(16):773-8. PubMed ID: 1165623 [TBL] [Abstract][Full Text] [Related]
52. Insulin secretion, insulin resistance, and obesity. DeFronzo RA Int J Obes; 1982; 6 Suppl 1():73-82. PubMed ID: 6749725 [No Abstract] [Full Text] [Related]
53. Human growth hormone as a regulator of blood glucose concentration and as a diabetogenic substance. Luft R; Cerasi E Diabetologia; 1968 Jan; 4(1):1-9. PubMed ID: 5741523 [No Abstract] [Full Text] [Related]
54. The interrelationship between insulin secretion and action in type 2 diabetes mellitus with different degrees of obesity: evidence supporting central obesity. Duman BS; Turkoglu C; Gunay D; Cagatay P; Demiroglu C; Buyukdevrim AS Diabetes Nutr Metab; 2003 Aug; 16(4):243-50. PubMed ID: 14768774 [TBL] [Abstract][Full Text] [Related]
55. Alimentary hypoglycemia in the absence of gastrointestinal surgery. Permutt MA; Kelly J; Berstein R; Alpers DH; Siegel BA; Kipnis DM N Engl J Med; 1973 Jun; 288(23):1206-10. PubMed ID: 4700554 [No Abstract] [Full Text] [Related]
56. Insulin secretion, carbohydrate tolerance, fat metabolism and body weight in maturity onset diabetics requiring various methods of therapy. Verlohren HJ; Ellorhaoui M; Lohmann D; Pohl A Endokrinologie; 1978 Apr; 71(2):192-203. PubMed ID: 97078 [TBL] [Abstract][Full Text] [Related]
57. [Prediabetic state. Realities and illusions]. Lestradet H Presse Med (1893); 1969 Jun; 77(29):1047-9. PubMed ID: 4893274 [No Abstract] [Full Text] [Related]
58. Some aspects of carbohydrate metabolism in Prader-Willi syndrome. Sareen C; Ruvalcaba RH; Kelley VC J Ment Defic Res; 1975 Jun; 19(2):113-9. PubMed ID: 1195356 [TBL] [Abstract][Full Text] [Related]
59. The effect of an adenosine--3'5'--monophosphate diesterase inhibitor (aminophylline) on the insulin response to glucose infusion in prediabetic and diabetic subjects. Cerasi E; Luft R Horm Metab Res; 1969 Jul; 1(4):162-8. PubMed ID: 4334871 [No Abstract] [Full Text] [Related]
60. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]